Product Name
CFAB Bb, Polyclonal Antibody
Full Product Name
CFAB Bb (Cleaved-Lys260) Antibody
Product Synonym Names
B-factor; properdin; C3 proaccelerator; C3 proactivator; C3/C5 convertase; CFAB; CFB; complement factor B; GBG; glycine-rich beta glycoprotein; PBF2; properdin factor B
Product Gene Name
anti-CFAB Bb antibody
[Similar Products]
Product Synonym Gene Name
CFB[Similar Products]
Research Use Only
For Research Use Only. Not for use in diagnostic procedures.
3D Structure
ModBase 3D Structure for P00751
Species Reactivity
Human, Mouse
Specificity
CFAB Bb (Cleaved-Lys260) Antibody detects endogenous levels of fragment of activated CFAB Bb resulting from cleavage adjacent to Lys260.
Purity/Purification
Purified from rabbit antiserum by affinity-chromatography using immunogen.
Form/Format
Rabbit IgG in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.
Concentration
1 mg/ml (lot specific)
Target Modification
Cleaved
Immunogen
The antiserum was produced against synthesized peptide derived from human CFAB Bb.
Preparation and Storage
Stable at -20 degree C for at least 1 year.
Other Notes
Small volumes of anti-CFAB Bb antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Applications Tested/Suitable for anti-CFAB Bb antibody
Western Blot (WB), ELISA (EIA)
Application Notes for anti-CFAB Bb antibody
WB: 1:500~1:1000
ELISA: 1:20000
NCBI/Uniprot data below describe general gene information for CFAB Bb. It may not necessarily be applicable to this product.
NCBI Accession #
NP_001701.2
[Other Products]
NCBI GenBank Nucleotide #
NM_001710.5
[Other Products]
UniProt Primary Accession #
P00751
[Other Products]
UniProt Secondary Accession #
O15006; Q29944; Q53F89; Q5JP67; Q5ST50; Q96HX6; Q9BTF5; Q9BX92; B0QZQ6[Other Products]
UniProt Related Accession #
P00751[Other Products]
Molecular Weight
57; 85 kDa
NCBI Official Full Name
complement factor B preproprotein
NCBI Official Synonym Full Names
complement factor B
NCBI Official Symbol
CFB??[Similar Products]
NCBI Official Synonym Symbols
BF; FB; BFD; GBG; CFAB; CFBD; PBF2; AHUS4; FBI12; H2-Bf; ARMD14
??[Similar Products]
NCBI Protein Information
complement factor B
UniProt Protein Name
Complement factor B
UniProt Synonym Protein Names
C3/C5 convertase; Glycine-rich beta glycoprotein; GBG
UniProt Gene Name
CFB??[Similar Products]
UniProt Synonym Gene Names
BF; BFD; GBG??[Similar Products]
NCBI Summary for CFAB Bb
This gene encodes complement factor B, a component of the alternative pathway of complement activation. Factor B circulates in the blood as a single chain polypeptide. Upon activation of the alternative pathway, it is cleaved by complement factor D yielding the noncatalytic chain Ba and the catalytic subunit Bb. The active subunit Bb is a serine protease which associates with C3b to form the alternative pathway C3 convertase. Bb is involved in the proliferation of preactivated B lymphocytes, while Ba inhibits their proliferation. This gene localizes to the major histocompatibility complex (MHC) class III region on chromosome 6. This cluster includes several genes involved in regulation of the immune reaction. Polymorphisms in this gene are associated with a reduced risk of age-related macular degeneration. The polyadenylation site of this gene is 421 bp from the 5' end of the gene for complement component 2. [provided by RefSeq, Jul 2008]
UniProt Comments for CFAB Bb
Factor B which is part of the alternate pathway of the complement system is cleaved by factor D into 2 fragments: Ba and Bb. Bb, a serine protease, then combines with complement factor 3b to generate the C3 or C5 convertase. It has also been implicated in proliferation and differentiation of preactivated B-lymphocytes, rapid spreading of peripheral blood monocytes, stimulation of lymphocyte blastogenesis and lysis of erythrocytes. Ba inhibits the proliferation of preactivated B-lymphocytes.
Research Articles on CFAB Bb
1. The complement activation factors Bb, C3a, C5a, and MAC were increased significantly in early-onset severe pre-eclampsia (EOSPE) (all P<.01) and late-onset severe pre-eclampsia (LOSPE). (P value: .027, <.001, .001, and <.001, respectively) compared with E/L-control. C1q and C4d were increased significantly in LOSPE (P value: .003 and .014, respectively) compared with L-control.
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.